Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.140
-0.310 (-8.99%)
At close: Nov 20, 2026, 4:00 PM EST
3.100
-0.040 (-1.27%)
After-hours: Nov 20, 2026, 7:49 PM EST
Inventiva Employees
Inventiva had 87 employees as of June 30, 2026. The number of employees increased by 10 or 12.99% since the number was reported on December 31, 2025.
Employees
87
Change
10
Growth
12.99%
Revenue / Employee
$32,252
Profits / Employee
-$3,253,046
Market Cap
761.40M
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 87 | 10 | 12.99% | 87 | 0 |
| Dec 31, 2025 | 77 | -41 | -34.75% | 69 | 8 |
| Dec 31, 2024 | 118 | -5 | -4.07% | 114 | 4 |
| Dec 31, 2023 | 123 | 10 | 8.85% | 120 | 3 |
| Dec 31, 2022 | 113 | 8 | 7.62% | 109 | 4 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Pharming Group | 407 |
| MeiraGTx Holdings | 386 |
| Syndax Pharmaceuticals | 298 |
| Rigel Pharmaceuticals | 174 |
| ORIC Pharmaceuticals | 119 |
| Verastem | 102 |
| Odyssey Therapeutics | 100 |
| Corvus Pharmaceuticals | 37 |
IVA News
- 11 days ago - Inventiva Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 16 days ago - Inventiva price target lowered to $14 from $24 at H.C. Wainwright - TheFly
- 5 weeks ago - Inventiva Slides: Corporate presentation - Filings
- 5 weeks ago - 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead - MarketBeat
- 6 weeks ago - Inventiva to Present Scientific Abstracts at AASLD The Liver Meeting® 2026 - GlobeNewsWire
- 6 weeks ago - Inventiva Eyes Q4 2026 Phase III MASH Data as Lanifibranor Nears Key Test - MarketBeat
- 7 weeks ago - Inventiva price target raised to $18 from $13 at Truist - TheFly
- 7 weeks ago - Inventiva Transcript: Stifel 2026 Virtual Cardiometabolic Forum - Transcripts